Relapse prevention with gepirone ER in outpatients with major depression

Journal of Clinical Psychopharmacology

Volumn 25, Issue 1, 2005, Pages 79-84

  Keller, Martin B ^a,e   Ruwe, Frank J L ^b   Janssens, Cecile J J G ^b   Sitsen, J M Ad ^b   Jokinen, Riitta ^c   Janczewski, Janusz ^d  

^a BROWN UNIVERSITY   (United States)

^b Clinical Development Department   (Netherlands)

^c Turun Psykiatripalvelu   (Finland)

^d Przy Zespole Opieki Zdrowotnej W C ^*  (Poland)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEPIRONE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; REMISSION; SIDE EFFECT; SINGLE BLIND PROCEDURE; VERTIGO;

ADULT; ANTIDEPRESSIVE AGENTS; DELAYED-ACTION PREPARATIONS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PYRIMIDINES; RECURRENCE; TREATMENT OUTCOME;

EID: 12344319999     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000150221.53877.d9     Document Type: Article

References (11)

1. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361:653-661.
2. Hirschfeld RMA. Long-term drug treatment of unipolar depression. Int Clin Psychopharmacol. 1996;11:211-217.
3. 1A agonists as antidepressants: pharmacological rationale and evidence for efficacy. CNS Drugs. 1998;10:343-353.
4. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse. 1987;1:470-480.
5. 1A receptor agonists. J Cardiovasc Pharmacol. 1990;15(suppl 7):S42-S48.
6. 1A receptors. J Neurosci. 1998;18:10150-10156.
7. Blier P, Ward NM. Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry. 2003;53:193-203.
8. Feiger AD, Heiser JF, Shrivastava RK, et al. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder. J Clin Psychiatry. 2003;64:243-249.
9. Robinson DS, Sitsen JA, Gibertini M. A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone. Clin Ther. 2003;25:1618-1633.
10. 1A agonists: a comparative review. CNS Drugs. 1994;2:234-251.
11. Dawson R, Lavori PW, Coryell WH. Maintenance strategies for unipolar depression: an observational study of levels of treatment and recurrence. J Affect Disord. 1998;49:31-44.